Printer Friendly

CAMBRIDGE BIOTECH CORPORATION APPOINTS NEW CHIEF FINANCIAL OFFICER

 WORCESTER, Mass., Aug.17 /PRNewswire/ -- Cambridge Biotech Corporation (NASDAQ:CBCX) today announced that James C. Bass will join the company as vice president and chief financial officer, effective Sept. 1, 1993.
 Bass replaces Peter P. Hartman, senior vice president and chief financial officer, who, for health reasons, will have to limit the time he can devote to the business.
 Most recently, Bass was a senior financial executive at Wang Laboratories, responsible for financial and controllership activities for subsidiary operations in thirteen countries in the Asia/Pacific and Latin American areas. He played a key role in the financial restructuring at Wang.
 Prior to joining Wang, Bass was with Bristol-Myers Squibb Company, where he held financial operating positions leading to general management. He began his career at Haskins and Sells, and is a C.P.A.
 Patrick J. Leonard, president and chief executive officer of Cambridge Biotech, commented: "The addition of this senior financial executive demonstrates our commitment to continue to move forward vigorously as a major player in international healthcare. Jim Bass brings impressive financial credentials and specific experience in the healthcare industry in the U.S. and abroad. His experience will be invaluable as we continue to generate short and long term capital, implement innovative strategies, and improve Cambridge Biotech's worldwide market share. Peter Hartman, during his tenure with the company as CFO, made a significant contribution. We will miss him as a friend and colleague and wish him well."
 Cambridge Biotech Corporation is a leading diagnostics and therapeutics company involved in infectious diseases. The company is developing vaccines, adjuvants and diagnostics for humans and animals.
 -0- 8/17/93
 /Contact: Frederick V. Casselman, vice president legal affairs & technology licensing; or Alyson Button Stone, coordinator of investor relations, ext. 541, both of Cambridge Biotech Corporation, 508-797-5777/
 (CBCX)


CO: Cambridge Biotech Corp., Wang ST: Massachusetts IN: MTC SU: PER

JL-CM -- NE009 -- 3466 08/17/93 10:33 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 17, 1993
Words:318
Previous Article:KOHL'S CORPORATION STOCKHOLDERS COMMENCE OFFERING OF COMMON STOCK
Next Article:/C O R R E C T I O N -- TIFFANY & CO./
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters